24/7 Wall St.

Why Crinetics Stock Soared 99% This Week

Crinetics Pharmaceuticals (NASDAQ:CRNX | CRNX Price Prediction) shares have climbed 99% just this week, from $42.03 at Monday ...

Vertex Is Paying a 102% Premium to Acquire Crinetics for $10 Billion. Here's Whether the Deal Is Worth It.

In the latest big-ticket deal in the pharmaceutical industry, Vertex Pharmaceuticals (VRTX 2.50%) and Crinetics ...
TimesLIVE

Defender Vertex trim upgrades launched in SA

JLR SA has released the new Defender Vertex models and introduced more upgrades for the range in South Africa.
JD Supra

FDA Expands Indication for Vertex’s CASGEVY to Children Aged Two Years and Older

On July 1, 2026, Vertex Pharmaceuticals announced that the FDA approved an expanded indication for CASGEVY (exagamglogene autotemcel) to ...
PMLive

Vertex to acquire Crinetics in deal worth around $10.0bn

Vertex Pharmaceuticals has agreed to acquire Crinetics Pharmaceuticals in a deal worth around $10.0bn. Crinetics is a global ...
Pharmabiz

Vertex Pharma to buy Crinetics Pharmaceuticals for $10 billion

Vertex Pharma to buy Crinetics Pharmaceuticals for $10 billion: Boston Wednesday, July 8, 2026, 14:00 Hrs [IST] Vertex Pharmaceuticals Incorporated, a global biotechnology company ...
Carscoops

Land Rover’s Defender Facelift Costs The Octa 93 HP, While The New Vertex Steals Its Angry Face

Here’s a fact that’s tricky for the JLR PR machine to spin: Land Rover has updated its Defender Octa performance flagship by junking 15 percent of its V8 horses. The flagship performance SUV loses 93 ...
Sickle Cell Disease News

FDA expands approval of sickle cell gene therapy to patients as young as 2

Casgevy is now approved in the U.S. for children with sickle cell as young as 2, becoming the first gene-editing therapy for ...

Vertex Sees Over $5 Billion Peak Sales Potential From Crinetics Assets

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) on Monday agreed to acquire Crinetics Pharmaceuticals Inc. (NASDAQ:CRNX) ...

Cantor Sees 'Clear Strategic Rationale' Behind Vertex's Buy of Crinetics — Market Talk

Vertex Pharmaceuticals' roughly $10 billion purchase of Crinetics Pharmaceuticals provides another near-term launch narrative with Palsonify, a treatment for acromegaly, Cantor analysts say in a ...

Vertex To Acquire Crinetics For ~$10bn - What Investors Should Know

Vertex Pharmaceuticals Incorporated’s $10B Crinetics Pharmaceuticals, Inc. buy adds PALSONIFY & a Phase 3 CAH asset. Click ...
Las Vegas Sun

Vertex to Acquire Crinetics Pharmaceuticals

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of ...